Tolerability and Plasma Drug Level Monitoring of Prolonged Subcutaneous Teicoplanin Treatment for Bone and Joint Infections

Teicoplanin is a key drug for the treatment of multiresistant staphylococcal bone and joint infections (BJI), yet can only be administered via a parenteral route. The objective of this study was to evaluate the safety and tolerability of subcutaneous (s.c.) teicoplanin for that indication over 42 da...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Antimicrob Agents Chemother
Главные авторы: El Samad, Youssef, Lanoix, Jean-Philippe, Bennis, Youssef, Diouf, Momar, Saroufim, Carlo, Brunschweiler, Benoit, Rousseau, Florence, Joseph, Cédric, Hamdad, Farida, Ait Amer Meziane, Mohamed, Routier, Simon, Schmit, Jean-Luc
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2016
Предметы:
Clinical Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5038334/
https://ncbi.nlm.nih.gov/pubmed/27458228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00351-16
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы